SCHEMBL524707

SCHEMBL524707

O=c1cccc(O)c(O)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DBH P09172 3/20 1.00
ALDH1A1 P00352 6/20 0.58
HPGD P15428 6/20 0.58
ALOX15 P16050 6/20 0.58
HSD17B10 Q99714 5/20 0.58
TDP1 Q9NUW8 5/20 0.58
CA2 P00918 5/20 0.58
LMNA P02545 4/20 0.58
CA1 P00915 4/20 0.58
CDK2 P24941 3/20 0.58
RECQL P46063 3/20 0.58
MMP2 P08253 2/20 0.58
EGFR P00533 2/20 0.58
FYN P06241 2/20 0.58
MMP9 P14780 2/20 0.58
ADAMTS4 O75173 1/20 0.58
MMP8 P22894 1/20 0.58
CA6 P23280 1/20 0.58
MMP12 P39900 1/20 0.58
ADAMTS5 Q9UNA0 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL524434 0.86 DBH (1.00) DBHALDH1A1HPGDALOX15HSD17B10
Pyrogallol SCHEMBL170157 0.75 ALDH1A1 (1.00) DBHALDH1A1HPGDALOX15HSD17B10
Pyrogallol SCHEMBL3532 0.75
SCHEMBL344192 0.74 ALDH1A1 (0.61) DBHALDH1A1HPGDALOX15HSD17B10
SCHEMBL1319163 0.74 CA12 (0.67) DBHALDH1A1HPGDCA2CA1
Pyrogallol SCHEMBL483095 0.73 ALDH1A1 (0.80) DBHALDH1A1HPGDALOX15HSD17B10
Pyrogallol SCHEMBL2063415 0.73 ALDH1A1 (0.80) DBHALDH1A1HPGDALOX15HSD17B10
Pyrogallol SCHEMBL25396043 0.72 ALDH1A1 (0.67) DBHALDH1A1HPGDALOX15HSD17B10
Pyrogallol SCHEMBL442053 0.72 ALDH1A1 (0.92) DBHALDH1A1HPGDALOX15HSD17B10
Pyrogallol SCHEMBL11324823 0.72 ALDH1A1 (0.92) DBHALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 643 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4316915-B1 ACTIVE NOISE CONTROL DEVICE, ACTIVE NOISE CONTROL METHOD, AND ACTIVE NOISE CONTROL PROGRAM TRANSTRON INC (JP) 2025-11-19 EP claimed
CN-119181111-A ACU-YOLO deep learning method for rapid human body acupoint recognition 燕山大学 2024-12-24 CN claimed
CN-119106716-A Power addition operation logic circuit construction method based on DNA domain coding 郑州西亚斯学院 2024-12-10 CN claimed
CN-118955042-A Water-retaining type side slope curing agent and preparation method and application thereof 成都理工大学 2024-11-15 CN claimed
US-11863018-B2 Reluctance motor NASHIKI MASAYUKI (JP) 2024-01-02 US claimed
EP-3298172-B1 DETERMINING RISK OF PROSTATE CANCER RECURRENCE UNIV CALIFORNIA (US) 2023-07-26 EP claimed
CN-116468221-A Ship power equipment maintenance task scheduling method and system 合肥工业大学 2023-07-21 CN claimed
US-20230172212-A1 COMPOSITIONS AND METHODS FOR PROMOTING SOIL MICROBIALS FOR PLANT HEATLTH AND STRESS TOLERANCE PHERONYM, INC. 2023-06-08 US claimed
CN-109837278-B Plant drought-induced synthetic promoter SP15 and application thereof 吉林农业大学 2022-11-04 CN claimed
CN-114907076-A Method for synergistically improving dynamic property and wave absorption property of concrete by using nano particles 中国人民解放军空军工程大学 2022-08-16 CN claimed
EP-3674859-B1 DISPLAY PANEL, DISPLAY DEVICE, AND DRIVING CIRCUIT LG DISPLAY CO LTD (KR) 2022-07-13 EP claimed
US-20100152301-A1 Treatment of Viral Infections GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2010-06-17 US claimed
EP-1976497-A2 TREATMENT OF VIRAL INFECTIONS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2008-10-08 EP claimed
WO-2007065007-A9 TREATMENT OF VIRAL INFECTIONS US HEALTH (US) 2007-09-13 WO claimed
WO-2007065007-A2 TREATMENT OF VIRAL INFECTIONS GOVERNMENT OF THE U.S.A., AS REPERSENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2007-06-07 WO claimed
CN-122094973-A T cell receptor 2026-05-26 CN disclosed
CN-122095300-A Array substrate and display device 2026-05-26 CN disclosed
WO-2007065007-A9 TREATMENT OF VIRAL INFECTIONS US HEALTH (US) 2007-09-13 WO disclosed
WO-2007065007-A2 TREATMENT OF VIRAL INFECTIONS GOVERNMENT OF THE U.S.A., AS REPERSENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2007-06-07 WO disclosed
WO-2006079792-A1 METHODS OF AUTOPHAGY INDUCTION IN MAMMALIAN CELLS CAMBRIDGE ENTERPRISE LIMITED (GB) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152301-A1 Treatment of Viral Infections CD4, TYMP, DUT DBH 1957/4885ALDH1A1 1004/4885HPGD 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.